DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

Arnaud Duchon, Yann Hérault|Frontiers in Behavioral Neuroscience|2016

Cited by 180